about
PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expressionIsoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk geneHuman respiratory syncytial virus N, P and M protein interactions in HEK-293T cellsCharacterization of NERF, a novel transcription factor related to the Ets factor ELF-1Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survivalGADD45 proteins: central players in tumorigenesisSoluble endoglin contributes to the pathogenesis of preeclampsiaA secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactionsNucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytesThe role of TNF-α in mice with type 1- and 2- diabetesHuman epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsBinding of the WASP/N-WASP-interacting protein WIP to actin regulates focal adhesion assembly and adhesionComplementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.Urine proteomic profiling of pediatric nephrotic syndrome.Analysis and robot pipelined automation for SELDI-TOF mass spectrometry.Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy.Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection.Proteomic identification of interleukin-2 therapy response in metastatic renal cell cancer.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.Gene expression analysis of embryonic stem cells expressing VE-cadherin (CD144) during endothelial differentiationDifferential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes.Genomic counter-stress changes induced by the relaxation response.Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancerIdentification of a novel potential biomarker in a model of hemorrhagic shock and valproic acid treatment.Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistanceA20 modulates lipid metabolism and energy production to promote liver regenerationComputational repositioning and preclinical validation of pentamidine for renal cell cancer.Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.c-Fos as a proapoptotic agent in TRAIL-induced apoptosis in prostate cancer cellsHuman T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells.Constitutive and cytokine-induced expression of the ETS transcription factor ESE-3 in the lung.Optimizing a proteomics platform for urine biomarker discoveryRequirement of the epithelium-specific Ets transcription factor Spdef for mucous gland cell function in the gastric antrum.Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4Molecular sequelae of proteasome inhibition in human multiple myeloma cellsTargeting transcription factors for cancer gene therapy.SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditionsRelaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways.Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.
P50
Q22011032-986DA058-FD17-4627-8363-FD6ED07ED1E7Q24309536-D2F9478F-7709-4D5C-A3CA-A8DA82569822Q24312875-DDBAD17B-CC79-4DF5-8608-EB28E15990F0Q24316274-D694A659-828D-41C8-810A-2DF32EE6BC88Q24336207-22DF0E5D-BD10-42A0-B4BF-AE4986101D3DQ24564706-2D138435-2280-421F-9CD3-44F67B78C5B5Q24608649-FCFCFBB1-EF22-4DBA-8E49-F6FAA75802FCQ28244053-EEF9F47B-E90C-48D8-AD19-513D76D8F102Q28254145-AD9D71CE-F300-413F-85CC-A197EC1B0C87Q28577590-F75E4B96-6B8E-4D75-9517-8B8EFF680034Q28730016-79585C6D-8A10-42B7-BB99-8FDFD48D3804Q29616544-A3CD993C-6E0D-4360-AD45-A0D84061C317Q30583693-FEFF90BE-DAC6-49D9-8A5E-0ED93C43EB75Q33184964-0D63F5A5-CA17-4C68-9211-78C8BC1389AAQ33248438-1C22300F-0818-4444-BC51-C440D1C2279CQ33271518-AB248A76-66E5-4DF7-B1A2-34BD3CCDE0E2Q33275899-5A98296C-47C5-43AB-9D57-564C6E88D420Q33309763-126407A7-47FF-4525-A261-8BBE205C4347Q33310515-E0229F7B-A6D7-43D3-846E-D0BD75F85756Q33316647-339FD95A-3EFA-469B-9D5C-4A71FD841FB3Q33337214-91CA8812-3E6D-4B58-83F4-6CD5740ADE00Q33346368-92C6F4C5-8722-4A7D-A705-8D198127AFEAQ33348641-028118B5-D24D-4D01-B47E-1CEB5F765648Q33387721-20487DC6-2EAF-4193-B5A3-5705BD5B3AD3Q33504961-0286CC49-C6FB-47EB-8296-79385DF03FFCQ33549674-2B0C04E6-F80E-4DC0-92C6-45A6AE629BE6Q33855522-5B618E6B-90A2-4F22-AB71-F949BEA8FC54Q33875574-D2494737-D5DE-4EB9-A83A-AE47BD738275Q34023344-60216417-BF2C-4203-8E8E-C87A5C1F24D1Q34139663-EDC73F36-D9DD-4C7C-A41C-76701055127FQ34146011-9CEB5711-C591-4286-AA7B-03D76B0B27A1Q34160084-C08F4F74-AC13-4259-8AD4-649997382579Q34214393-7B23F530-701D-4925-9F63-1E49690479BBQ34251439-9830F683-709F-4B3F-81C4-230D0AA15F7CQ34315374-DC445D19-4F98-41AF-A506-9A4E9F739EE9Q34393832-63222600-D444-45AC-81CC-52F2914FE43EQ34494104-3210FF0B-FA07-456E-BA60-6373F62E570BQ34565495-9C20637E-2F9C-4009-8C8D-2B55BDA569E2Q34651549-5052E5E1-D63C-4121-B214-9C4E70915966Q35125173-D6968AA4-B4D0-4A70-AEDD-F08D516BE3AF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Towia A Libermann
@ast
Towia A Libermann
@en
Towia A Libermann
@es
Towia A Libermann
@nl
Towia A Libermann
@sl
type
label
Towia A Libermann
@ast
Towia A Libermann
@en
Towia A Libermann
@es
Towia A Libermann
@nl
Towia A Libermann
@sl
prefLabel
Towia A Libermann
@ast
Towia A Libermann
@en
Towia A Libermann
@es
Towia A Libermann
@nl
Towia A Libermann
@sl
P106
P31
P496
0000-0002-4006-8179